Cempra develops novel, well-differentiated antibiotics to meet critical unmet medical needs. Two lead products, both in clinical-stage development, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.
View Top Employees from Cempra PharmaceuticalsWebsite | http://www.cempra.com |
Ticker | NASDAQ:CEMP |
Revenue | $18 million |
Funding | $172 million |
Employees | 13 (13 on RocketReach) |
Founded | 2006 |
Address | 6320 Quadrangle Drive Suite 360, Chapel Hill, North Carolina 27517, US |
Phone | (312) 767-0291 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Clinical Trials, Health Care, Pharmaceutical |
Web Rank | 28 Million |
Keywords | Melinta Chapel Hill |
Competitors | MGB Biopharma Limited, Sequella, Inc., Spero Therapeutics, Tetraphase Pharmaceuticals, VTV |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Cempra Pharmaceuticals employee's phone or email?
The Cempra Pharmaceuticals annual revenue was $18 million in 2024.
Kenneth Touw is the Executive Vice President, Regulatory Affairs of Cempra Pharmaceuticals.
13 people are employed at Cempra Pharmaceuticals.
Cempra Pharmaceuticals is based in Chapel Hill, North Carolina.
The NAICS codes for Cempra Pharmaceuticals are [3254, 325414, 325, 32, 32541].
The SIC codes for Cempra Pharmaceuticals are [283, 28].